Gokhale Sankalp, Khan Shariq A, McDonagh David L, Britz Gavin
Division of Neurocritical Care, Department of Neurology, Duke University Hospital, Duke University School of Medicine, Durham, NC 27710, USA.
Division of Neuro-anesthesia, Department of Anesthesiology, Duke University Hospital, Duke University School of Medicine, Durham, NC 27710, USA.
Surg Neurol Int. 2014 Jan 21;5:7. doi: 10.4103/2152-7806.125628. eCollection 2014.
Spinal dural arteriovenous fistula (SDAVF) is a rare spinal vascular malformation with an annual incidence of 5-10 cases per million. The data on efficacy, recurrence rates and complications of endovascular versus surgical treatment of SDAVF is limited.
We conducted a retrospective chart review of 27 adult patients with a diagnosis of SDAVF and who underwent treatment at Duke University Hospital between January 1, 1993 and December 31, 2012. We compared the outcome measures by Aminoff-Logue score (ALS) in patients who underwent treatment with endovascular embolization versus surgical ligation of fistula. We compared complication rates, recurrence rates as well as data on long-term follow up in these patients.
Out of 27 patients in the study, 10 patients underwent endovascular embolization (Onyx was used in 5 patients and NBCA in 5 patients) as the first line therapy. Seventeen patients underwent surgical ligation as initial therapeutic modality. Patients in both groups showed significant improvement in clinical status (ALS) after treatment. One patient in endovascular group developed spinal infarction due to accidental embolization of medullary artery. Three patients in embolization group had recurrence of fistula during the course of follow up requiring surgical ligation. Two patients in surgical group developed local wound infection. None of the patients in surgical group had recurrence of fistula during the course of follow up.
Endovascular embolization and surgical ligation are effective treatment strategies for SDAVF. Our observations show that surgical ligation may offer permanent cure without any recurrence. Endovascular approach is associated with higher incidence of recurrence, especially with use of onyx.
脊髓硬脊膜动静脉瘘(SDAVF)是一种罕见的脊髓血管畸形,年发病率为百万分之5 - 10例。关于SDAVF血管内治疗与手术治疗的疗效、复发率及并发症的数据有限。
我们对1993年1月1日至2012年12月31日期间在杜克大学医院诊断为SDAVF并接受治疗的27例成年患者进行了回顾性病历审查。我们比较了接受血管内栓塞治疗与手术结扎瘘管的患者的阿明诺夫 - 洛格评分(ALS)的结果指标。我们比较了这些患者的并发症发生率、复发率以及长期随访数据。
在该研究的27例患者中,10例患者接受血管内栓塞作为一线治疗(5例使用Onyx,5例使用NBCA)。17例患者接受手术结扎作为初始治疗方式。两组患者治疗后临床状况(ALS)均有显著改善。血管内治疗组有1例患者因脊髓动脉意外栓塞发生脊髓梗死。栓塞治疗组有3例患者在随访过程中瘘管复发,需要进行手术结扎。手术组有2例患者发生局部伤口感染。手术组患者在随访过程中均无瘘管复发。
血管内栓塞和手术结扎是治疗SDAVF的有效策略。我们的观察表明,手术结扎可能提供永久性治愈且无任何复发。血管内治疗方法的复发率较高,尤其是使用Onyx时。